MXCT vs WDAY · rev $38.6M vs P/E 135, rev $8.45B
MaxCyte Inc (MXCT) versus Workday Inc (WDAY) — a side-by-side from cached financials, not a winner call.
MaxCyte Inc (MXCT) is a medical devices company listed on NASDAQ.
Workday Inc (WDAY) is a software - application company listed on US.
Latest reported MXCT revenue for 2024-12-31 was $38.6M. Net income was -$41.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. MXCT currently screens at market cap $124.3M.
Latest reported WDAY revenue for 2025-01-31 was $8.45B. Net income was $526.0M. Revenue was up 16.4% from 2024-01-31 to 2025-01-31. WDAY currently screens at market cap $64.45B and trailing P/E 135.1.
MXCT currently screens at market cap $124.3M. WDAY currently screens at market cap $64.45B and trailing P/E 135.1.
Not investment advice. Open the MXCT and WDAY stock pages for the full models.
Not investment advice.